Literature DB >> 30683937

Ex vivo and in vivo stable isotope labelling of central carbon metabolism and related pathways with analysis by LC-MS/MS.

Min Yuan1,2, Daniel M Kremer3,4, He Huang1,2,5, Susanne B Breitkopf1,2,5, Issam Ben-Sahra6, Brendan D Manning7, Costas A Lyssiotis8,9,10, John M Asara11,12,13.   

Abstract

Targeted tandem mass spectrometry (LC-MS/MS) has been extremely useful for profiling small molecules extracted from biological sources, such as cells, bodily fluids and tissues. Here, we present a protocol for analysing incorporation of the non-radioactive stable isotopes carbon-13 (13C) and nitrogen-15 (15N) into polar metabolites in central carbon metabolism and related pathways. Our platform utilizes selected reaction monitoring (SRM) with polarity switching and amide hydrophilic interaction liquid chromatography (HILIC) to capture transitions for carbon and nitrogen incorporation into selected metabolites using a hybrid triple quadrupole (QQQ) mass spectrometer. This protocol represents an extension of a previously published protocol for targeted metabolomics of unlabeled species and has been used extensively in tracing the metabolism of nutrients such as 13C-labeled glucose, 13C-glutamine and 15N-glutamine in a variety of biological settings (e.g., cell culture experiments and in vivo mouse labelling via i.p. injection). SRM signals are integrated to produce an array of peak areas for each labelling form that serve as the output for further analysis. The processed data are then used to obtain the degree and distribution of labelling of the targeted molecules (termed fluxomics). Each method can be customized on the basis of known unlabeled Q1/Q3 SRM transitions and adjusted to account for the corresponding 13C or 15N incorporation. The entire procedure takes ~6-7 h for a single sample from experimental labelling and metabolite extraction to peak integration.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30683937      PMCID: PMC7382369          DOI: 10.1038/s41596-018-0102-x

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  37 in total

1.  A universal framework for 13C metabolic flux analysis.

Authors:  W Wiechert; M Möllney; S Petersen; A A de Graaf
Journal:  Metab Eng       Date:  2001-07       Impact factor: 9.783

2.  Determination of metabolic flux ratios from 13C-experiments and gas chromatography-mass spectrometry data: protocol and principles.

Authors:  Annik Nanchen; Tobias Fuhrer; Uwe Sauer
Journal:  Methods Mol Biol       Date:  2007

3.  (13)C-based metabolic flux analysis.

Authors:  Nicola Zamboni; Sarah-Maria Fendt; Martin Rühl; Uwe Sauer
Journal:  Nat Protoc       Date:  2009-05-21       Impact factor: 13.491

Review 4.  Novel biological insights through metabolomics and 13C-flux analysis.

Authors:  Nicola Zamboni; Uwe Sauer
Journal:  Curr Opin Microbiol       Date:  2009-09-08       Impact factor: 7.934

5.  Metabolic Heterogeneity in Human Lung Tumors.

Authors:  Christopher T Hensley; Brandon Faubert; Qing Yuan; Naama Lev-Cohain; Eunsook Jin; Jiyeon Kim; Lei Jiang; Bookyung Ko; Rachael Skelton; Laurin Loudat; Michelle Wodzak; Claire Klimko; Elizabeth McMillan; Yasmeen Butt; Min Ni; Dwight Oliver; Jose Torrealba; Craig R Malloy; Kemp Kernstine; Robert E Lenkinski; Ralph J DeBerardinis
Journal:  Cell       Date:  2016-02-04       Impact factor: 41.582

6.  Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer.

Authors:  Shawn M Davidson; Thales Papagiannakopoulos; Benjamin A Olenchock; Julia E Heyman; Mark A Keibler; Alba Luengo; Matthew R Bauer; Abhishek K Jha; James P O'Brien; Kerry A Pierce; Dan Y Gui; Lucas B Sullivan; Thomas M Wasylenko; Lakshmipriya Subbaraj; Christopher R Chin; Gregory Stephanopolous; Bryan T Mott; Tyler Jacks; Clary B Clish; Matthew G Vander Heiden
Journal:  Cell Metab       Date:  2016-02-04       Impact factor: 27.287

7.  Loss of RBF1 changes glutamine catabolism.

Authors:  Brandon N Nicolay; Paulo A Gameiro; Katrin Tschöp; Michael Korenjak; Andreas M Heilmann; John M Asara; Gregory Stephanopoulos; Othon Iliopoulos; Nicholas J Dyson
Journal:  Genes Dev       Date:  2013-01-15       Impact factor: 11.361

8.  Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1.

Authors:  Issam Ben-Sahra; Jessica J Howell; John M Asara; Brendan D Manning
Journal:  Science       Date:  2013-02-21       Impact factor: 47.728

9.  Optimal tracers for parallel labeling experiments and 13C metabolic flux analysis: A new precision and synergy scoring system.

Authors:  Scott B Crown; Christopher P Long; Maciek R Antoniewicz
Journal:  Metab Eng       Date:  2016-06-04       Impact factor: 9.783

10.  13C Tracer Studies of Metabolism in Mouse Tumor Xenografts.

Authors:  Andrew N Lane; Jun Yan; Teresa W-M Fan
Journal:  Bio Protoc       Date:  2015-11-20
View more
  36 in total

1.  IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex.

Authors:  Alexander J Valvezan; Molly C McNamara; Spencer K Miller; Margaret E Torrence; John M Asara; Elizabeth P Henske; Brendan D Manning
Journal:  JCI Insight       Date:  2020-04-09

2.  Combining Isotopologue Workflows and Simultaneous Multidimensional Separations to Detect, Identify, and Validate Metabolites in Untargeted Analyses.

Authors:  James N Dodds; Lingjue Wang; Gary J Patti; Erin S Baker
Journal:  Anal Chem       Date:  2022-01-28       Impact factor: 6.986

3.  Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells.

Authors:  Ji Wang; Harilaos Filippakis; Thomas Hougard; Heng Du; Chenyang Ye; Heng-Jia Liu; Long Zhang; Khadijah Hindi; Shefali Bagwe; Julie Nijmeh; John M Asara; Wei Shi; Souheil El-Chemaly; Elizabeth P Henske; Hilaire C Lam
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-28       Impact factor: 11.205

4.  The mTORC1-SLC4A7 axis stimulates bicarbonate import to enhance de novo nucleotide synthesis.

Authors:  Eunus S Ali; Anna Lipońska; Brendan P O'Hara; David R Amici; Michael D Torno; Peng Gao; John M Asara; Mee-Ngan F Yap; Marc L Mendillo; Issam Ben-Sahra
Journal:  Mol Cell       Date:  2022-06-29       Impact factor: 19.328

Review 5.  Stable isotope tracing to assess tumor metabolism in vivo.

Authors:  Brandon Faubert; Alpaslan Tasdogan; Sean J Morrison; Thomas P Mathews; Ralph J DeBerardinis
Journal:  Nat Protoc       Date:  2021-09-17       Impact factor: 17.021

6.  ERK2 Phosphorylates PFAS to Mediate Posttranslational Control of De Novo Purine Synthesis.

Authors:  Eunus S Ali; Umakant Sahu; Elodie Villa; Brendan P O'Hara; Peng Gao; Cynthia Beaudet; Antony W Wood; John M Asara; Issam Ben-Sahra
Journal:  Mol Cell       Date:  2020-06-01       Impact factor: 17.970

7.  mTORC1 stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis.

Authors:  Elodie Villa; Umakant Sahu; Brendan P O'Hara; Eunus S Ali; Kathryn A Helmin; John M Asara; Peng Gao; Benjamin D Singer; Issam Ben-Sahra
Journal:  Mol Cell       Date:  2021-03-22       Impact factor: 17.970

8.  HIF-2α activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron.

Authors:  Rashi Singhal; Sreedhar R Mitta; Nupur K Das; Samuel A Kerk; Peter Sajjakulnukit; Sumeet Solanki; Anthony Andren; Roshan Kumar; Kenneth P Olive; Ruma Banerjee; Costas A Lyssiotis; Yatrik M Shah
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

9.  Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy.

Authors:  Renee C Geck; Jackson R Foley; Tracy Murray Stewart; John M Asara; Robert A Casero; Alex Toker
Journal:  J Biol Chem       Date:  2020-03-05       Impact factor: 5.157

10.  Peroxisomal-derived ether phospholipids link nucleotides to respirasome assembly.

Authors:  Christopher F Bennett; Katherine E O'Malley; Elizabeth A Perry; Eduardo Balsa; Pedro Latorre-Muro; Christopher L Riley; Chi Luo; Mark Jedrychowski; Steven P Gygi; Pere Puigserver
Journal:  Nat Chem Biol       Date:  2021-03-15       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.